In addition, this data agrees with the study of Huang et al. in which authors demonstrated that BMP-2 can promote EMT in breast cancer via phosphatidylinositol 3-kinases/protein kinase B pathway (PI3K/Akt) [5], a cellular signaling that can be regulated both at extracellular and cytoplasmatic level. Here, AKT1 is linked to breast cancer.